This Month
Citron’s Andrew Left faces US criminal charges over alleged fraud
US authorities allege that Left promoted what he said were his long or short trades, only to quickly reverse his positions, pocketing profits in the process.
- Chris Prentice
End of the road comes in two-decade saga over sandalwood group Quintis
The company once known as TFS Corporation will be split up and liquidated after KordaMentha failed to find a buyer for the entire business.
- Simon Evans
Phil King’s Regal Partners set for major payday after banner year
Soaring funds under management and strong performance pushed fees at the investment house, which has snapped up several rivals this year, to record levels.
- Joshua Peach
June
Why Regal’s Phil King is shorting CBA
The Regal Partners investment chief has made the so-called “widowmaker” trade in betting against the nation’s largest bank.
- Joshua Peach
Ellerston Capital snaps up IDP Education stake, hoping for rebound
The boutique fund manager’s Chris Kourtis told clients that the immigration restrictions weighing on the share price had created an “attractive entry point”.
- Joshua Peach
May
Regal allegedly embroiled in South Korean securities investigation
The prominent hedge fund told investors in September it was shorting stocks in South Korea, saying it was focused on “one specific bank”.
- Joshua Peach
Hedge funds are once again targeting Qantas
Almost $300 million has been bet against Australia’s largest airline, even as it attempts to repair its relationship with customers after selling tickets on flights that were already cancelled.
- Joshua Peach
These 5 ETFs posted double-digit returns in April’s shock sell-off
The fall in global sharemarkets stopped the fast-growing ETF industry in its tracks in April, but proved profitable for several short-style strategies.
- Updated
- Joshua Peach
April
Regal’s Phil King shorts Tesla and Apple
The star stockpicker says there’s long and short opportunities in the Magnificent Seven, and his fund is playing both sides.
- Joshua Peach
Why Wall Street banks have got it wrong on lithium
Sydney fund manager Ethical Partners says their own modelling shows the battery metal has moved “rapidly back” into balance after last year’s collapse, that will continue to support prices (and the sharemarket).
- Sarah Jones
Why this US short seller is spooked by Australia
US-based Australian manager Nathan Koppikar says the ASX is too dominated by super funds and investor cliques – and other hedge funds agree.
- Matthew Cranston
March
Reddit tumbles after Hedgeye names it a short-selling idea
Hedgeye Risk Management said the stock was “grossly overvalued” and should trade closer to its IPO price of $US34.
- Carmen Reinicke
The ‘junk stock’ rally is heaping pressure on hedge funds
The months-long surge in the ASX 200 has wrong-footed several prominent local hedge funds, with the rally pulling some long-short strategies into the red.
- Joshua Peach
BoQ backs Temenos amid claims software provider selling ‘vapourware’
Activist investor Hindenburg Research alleges the company has employed aggressive accounting practices and sold faulty products to local lenders.
- Lucas Baird
ASX caught in billion-dollar short squeeze as hedge funds shuffle bets
Portfolio managers exited almost $1 billion in short bets against some of the ASX’s most beaten-up stocks, likely adding to a surge in volatility in February.
- Joshua Peach
February
Hindenburg short attack puts Aussie banks in the crosshairs
The short-seller’s latest target Temenos is a prolific supplier to Australian banking minnows.
- Lucas Baird
Lovisa short sellers squeezed as stock rallies to all-time high
The number of short sellers betting against the discount jewellery retailer surged to the highest level in four years ahead of the results, but that hasn’t stopped the stock rallying to all-time highs.
- Updated
- Joshua Peach and Carrie LaFrenz
‘Total flop’: Neuren Pharma sinks 14pc on short-seller report
The Melbourne biotech darling has rebuked Culper Research’s allegation that its US partner had “misrepresented” its drug’s safety and patient retention rate.
- Joshua Peach
Lithium stocks leading short bets as earnings season kicks off
Despite another step down in the share prices of several lithium stocks during January, hedge funds are holding firm on bets the sector could sink further.
- Joshua Peach
January
Best short call of 2023 belongs to an amateur sleuth
James Block’s call on Signature Bank topped a list of short bets including Nate Anderson’s Hindenburg Research and Fraser Perring’s Viceroy Research.
- Sam Potter